Last update 08 May 2025

VIO-001

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
meropenem + piperacillin + tazobactam (Viosera Therapeutics)
Target
Penicillin binding protein 1A x Penicillin binding protein 2 x β-lactamase
Action
inhibitors
Mechanism
Penicillin binding protein 1A inhibitors, Penicillin binding protein 2 inhibitors, β-lactamase inhibitors(Beta Lactamase inhibitors)
Therapeutic Areas
Infectious Diseases
Active Indication
Staphylococcal Infections
Inactive Indication-
Originator Organization
Weill Medical College of Cornell UniversityWeill Medical College of Cornell University
Active Organization
Viosera Therapeutics Inc.Viosera Therapeutics Inc.
Weill Medical College of Cornell UniversityWeill Medical College of Cornell University
Inactive Organization-
License Organization
Weill Medical College of Cornell UniversityWeill Medical College of Cornell UniversityViosera Therapeutics Inc.Viosera Therapeutics Inc.
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with VIO-001
Login to view more data
100 Translational Medicine associated with VIO-001
Login to view more data
100 Patents (Medical) associated with VIO-001
Login to view more data
1
Literatures (Medical) associated with VIO-001
18 Oct 2021Antimicrobial Agents and ChemotherapyQ2 · MEDICINE
Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 (Meropenem/Piperacillin/Tazobactam) for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia in Immunocompetent Rabbits with Chronic Indwelling Vascular Catheters
Q2 · MEDICINE
100 Deals associated with VIO-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Staphylococcal InfectionsPreclinical
United States
Viosera Therapeutics Inc.Viosera Therapeutics Inc.
-
Staphylococcal InfectionsPreclinical
United States
Weill Medical College of Cornell UniversityWeill Medical College of Cornell University
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free